Fig. 3

Self-reported HCV history of treatment (ever been treated) among anti-HCV positive tested participants, DRUCK-study (2011–2014, N = 1.361) and DRUCK 2.0 study (2021–2022, N = 432)
Self-reported HCV history of treatment (ever been treated) among anti-HCV positive tested participants, DRUCK-study (2011–2014, N = 1.361) and DRUCK 2.0 study (2021–2022, N = 432)